Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Operating Margin (2018 - 2021)

GT Biopharma (GTBP) has disclosed Operating Margin for 6 consecutive years, with 82627.27% as the latest value for Q4 2021.

  • On a quarterly basis, Operating Margin changed N/A to 82627.27% in Q4 2021 year-over-year; TTM through Dec 2021 was 261431.82%, a N/A change, with the full-year FY2025 number at 9781.1%, changed N/A from a year prior.
  • Operating Margin was 82627.27% for Q4 2021 at GT Biopharma, up from 7264.1% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 82627.27% in Q4 2021 to a low of 475.78% in Q2 2019.